The Egg Up Trial - Testing a New Treatment Pathway for Infants With Newly Diagnosed Egg Allergy
The goal of this study is to test the safety and feasibility of a change in management approach for infants with newly diagnosed egg allergy. Infants with newly diagnosed egg allergy will have egg introduced via a gradual and graded home based approach known as an "egg ladder" supervised by a dietitian. The main questions this study aims to answer are how safe and feasible are home-based dietitian-led "egg ladders" as a treatment pathway to achieve tolerance of egg for newly diagnosed infants with egg allergy.
- EligibilityCriteria: Inclusion Criteria:  infants aged greater than 4 months and less than 12 months of age diagnosed by an RCH allergist with IgE- mediated egg allergy in conjunction with a positive skin prick test (SPT) or specific immunoglobulin E (sIgE) to egg white has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participants behalf  Exclusion Criteria:  any history of severe food induced anaphylaxis. Defined as reaction requiring 2 doses of intermuscular adrenalin Physician diagnosed recurrent wheeze Not commenced or unable to eat solid food prescribed beta-blocker medication - HealthyVolunteers: Accepts Healthy Volunteers - Gender: All - MinimumAge: 4 Months - MaximumAge: 12 Months - StdAgeList: Child